Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Susanna Grimaudo"'
Autor:
Maria Chiara Tronconi, Arianna Marinello, Alessandra Solferino, Susanna Grimaudo, Michele Ciccarelli, Sofia Manara, Luca Cozzaglio, Luca Mancini, Riccardo Borroni, Armando Santoro
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 2, Pp 560-565 (2022)
BRAF inhibitors (BRAFi) and MEK inhibitors (MEKi) exert a cytotoxic and immune-mediated effect on metastatic melanoma. The immune-mediated mechanism can lead to some adverse events, including panniculitis, erythema, keratitis, vitiligo-like lesions,
Externí odkaz:
https://doaj.org/article/860548fe8e224a518620fc613363ac8c
Autor:
Alexia Francesca Bertuzzi, Maria Susanna Grimaudo, Alice Laffi, Laura Giordano, Nicolò Gennaro, Umberto Cariboni, Licia Vanessa Siracusano, Vittorio Quagliuolo, Piergiuseppe Colombo, D’Orazio Federico, Salvatore Lorenzo Renne, Cristina Specchia, Ferdinando Cananzi, Andrea Marrari, Pierina Navarria, Primo Andrea Daolio, Stefano Bastoni, Armando Santoro
Publikováno v:
Cancer Medicine, Vol 12, Iss 15, Pp 16254-16263 (2023)
Abstract Introduction The aim of this retrospective study was to investigate the clinicopathological characteristics of AYA sarcomas and their clinical outcomes at a high‐volume single center. Methods Demographic, clinicopathological data on the di
Externí odkaz:
https://doaj.org/article/7e41660ffae240f593090873594dd21e
Autor:
Maria Susanna Grimaudo, Alice Laffi, Nicolò Gennaro, Roberta Fazio, Federico D’Orazio, Laura Samà, Licia Vanessa Siracusano, Federico Sicoli, Salvatore Lorenzo Renne, Armando Santoro, Alexia Francesca Bertuzzi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionRegorafenib is a tyrosine kinase inhibitor (TKI) approved in metastatic gastrointestinal stromal tumor (GIST), colorectal cancer, and hepatocarcinoma. Anyway, the toxicity profile of Regorafenib standard schedule is associated with poor c
Externí odkaz:
https://doaj.org/article/fa4e4a38a65349a0a1ca77fcb062dc2e
Autor:
Chiara Poggio, Carlotta Pavesi, Maria Susanna Grimaudo, Diego Lopane, Annalisa Saetta, Laura Giordano, Luca Cullia, Chiara Provasoli, Santina Giuffrè, Laura Velutti, Nunzio Digiacomo, Antonella Cammarota, Arianna Marinello, Elisabetta Villa, Stefano Ferrari, Frederico Gonçalves Pereira, Lorenza Rimassa, Armando Santoro
Publikováno v:
Journal of Clinical Oncology. 37:65-65
65 Background: Cancer patients (pts) are often treated with anticancer therapy (CT) even in the last months of life and are often hospitalized through an access to the emergency room (ERa). This is frequently the time when a palliative care (PC) serv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c93aa742175b0876769d712a86928291
https://doi.org/10.1200/jco.2019.37.31_suppl.65
https://doi.org/10.1200/jco.2019.37.31_suppl.65